Article Information
History
- February 18, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mitangala Ndeba Prudence1,2,#,
- Irenge Mwana Wa Bene Léonid3,4,#,
- Musubao Tsongo Edgar5,
- Kahindo Mbeva Jean Bosco2,
- Ayonga Ndeba Patrick6,
- Safari Kyembwa Israël7,
- Kubuya Bonane Janvier8,
- Ntabe Namegabe Edmon9,
- Kabangwa Kakongo Senga Raphaël10,
- Mutombo Ndongala Guy8,
- Jérôme Ambroise3 and
- Jean-Luc Gala3,*
- 1Université Catholique de Bukavu, Bukavu, Sud Kivu, Democratic Republic of Congo
- 2Université Officielle de Ruwenzori, Butembo, Nord Kivu, Democratic Republic of Congo
- 3Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 54/B1.54.01, 1200 Woluwe-Saint-Lambert, Belgium
- 4Defence Laboratories Department, ACOS Ops&Trg, Peutie, Belgium
- 5Institut de Techniques Médicales, Goma, Nord Kivu, Democratic Republic of Congo
- 6Département des maladies infectieuses et tropicales, Université de Bordeaux, France
- 7Inspection provinciale de la santé du Nord Kivu, Democratic Republic of Congo
- 8Division provinciale de la santé du Nord Kivu, Democratic Republic of Congo
- 9Université Libre des Pays des Grands Lacs, Goma Nord Kivu, Democratic Republic of Congo
- 10Laboratoire Provincial Ami Labo Nord Kivu, Democratic Republic of Congo
- ↵*Author for correspondence:
Jean-Luc Gala, E-mail: jean-luc.gala{at}uclouvain.be
↵# Both authors contributed equally
Posted February 18, 2023.
Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of Congo
